Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevudine versus adefovir in treatment-naive HBeAg-negative chronic hepatitis B
2007-001063-30Phase 3Terminated
- Sponsor
- Pharmasset Inc.
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Chronic Hepatitis B (CHB) comparing Clevudine with Adefovir dipivoxil (2 arms). Primary endpoint: Composite response rate at Week 48. Started May 2007; status: terminated.
02
Drugs
clevudineadefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2007-001063-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001063-30.